Erratum To: Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies With Supporting Preclinical Evidence

CNS Drugs - United Kingdom
doi 10.1007/s40263-013-0087-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Medicinal Plants With Antimicrobial Activities (Part 2): Plant Based Review

Scholars Academic Journal of Pharmacy
2016English

Review of Preclinical and Clinical Studies of Using Cell‐based Therapy for Secondary Lymphedema

Journal of Surgical Oncology
MedicineSurgeryOncology
2019English

Ozone: A Review of Recent Experimental, Clinical and Epidemiological Evidence, With Notes on Causation—Part 2

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1995English

Adherence to Evidence-Based Guidelines for Depression and Anxiety Disorders Is Associated With Recording of the Diagnosis

General Hospital Psychiatry
PsychiatryMental Health
2009English

Clinical Studies on Anxiety About Dental Treatment. Part I.

Japanese Journal of Oral & Maxillofacial Surgery
1975English

Medicinal Plants With Antioxidant and Free Radical Scavenging Effects (Part 2): Plant Based Review

IOSR Journal of Pharmacy (IOSRPHR)
2016English

Cognitive-Behavioral Psychotherapy for Anxiety and Depressive Disorders in Children and Adolescents: An Evidence-Based Medicine Review

Journal of the American Academy of Child and Adolescent Psychiatry
PsychiatryDevelopmentalMental HealthEducational Psychology
2004English

Treatment of Anxiety Disorders in Clinical Practice: A Critical Overview of Recent Systematic Evidence

Clinics
Medicine
2019English

Neuropharmacology of Anxiety Disorders at Young Age: A Perspective From Preclinical Research

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy